Skip to content

Clinical trials

Hemoglobinuria, Paroxysmal trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemoglobinuria, Paroxysmal Country / region: Italy Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20051
20111
20121
20162
20173
20182
20193
20202
20214
20223
20233
20241
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Recruiting6
Active, not recruiting5
Terminated3
Available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alexion Pharmaceuticals, Inc.17
Novartis Pharmaceuticals7
Regeneron Pharmaceuticals3
Hoffmann-La Roche2
Amgen1
BioCryst Pharmaceuticals1
Istituto Giannina Gaslini1
Swedish Orphan Biovitrum1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemoglobinuria, Paroxysmal33
Hemolysis6
Anemia5
Hemoglobinuria2
Atypical Hemolytic Uremic Syndrome1
Congenital Bone Marrow Failure Syndromes1
Dyskeratosis Congenita1
Fanconi Anemia1
Myasthenia Gravis1
Neuromyelitis Optica1

Trials

Showing 51 to 33 of 33. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.